
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems Langfristiger Schuldenstrom 2011-2026 | TTOO
Langfristiger Schuldenstrom Jährlich T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 M | 1.35 M | 1.17 M | 1.15 M | 1.98 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.98 M | 1.15 M | 1.46 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.12 | -0.88 % | $ 1.42 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 24.58 | 1.91 % | $ 99.4 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 11.26 | - | $ 319 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
172 K | $ 106.01 | 0.82 % | $ 4.18 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 23.02 | 0.04 % | $ 696 M | ||
|
Co-Diagnostics
CODX
|
838 K | - | - | $ 79.8 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 209.34 | 0.95 % | $ 23.2 B | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 30.02 | 3.73 % | $ 834 M | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 19.18 | 2.08 % | $ 1.03 B | ||
|
Danaher Corporation
DHR
|
173 M | $ 209.79 | -0.58 % | $ 153 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
DexCom
DXCM
|
21.6 M | $ 72.99 | -0.38 % | $ 28.5 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Interpace Biosciences
IDXG
|
383 K | $ 1.74 | -5.95 % | $ 7.63 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.46 | 0.07 % | $ 19.5 B | ||
|
Guardant Health
GH
|
27.7 M | $ 96.45 | 2.15 % | $ 12.1 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
185 M | $ 287.1 | 0.62 % | $ 24.1 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 382.99 | -0.81 % | $ 28.5 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 166.77 | 1.98 % | $ 8.27 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
OPKO Health
OPK
|
12.6 M | $ 1.15 | -0.43 % | $ 798 M | ||
|
Pacific Biosciences of California
PACB
|
9.59 M | $ 1.66 | 5.06 % | $ 421 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 104.81 | 0.14 % | $ 8.65 B | ||
|
ENDRA Life Sciences
NDRA
|
96.9 K | $ 3.77 | 0.53 % | $ 2.02 M | ||
|
IDEXX Laboratories
IDXX
|
27.1 M | $ 648.66 | 4.1 % | $ 52.2 B | ||
|
Illumina
ILMN
|
79 M | $ 123.46 | 2.42 % | $ 19.6 B | ||
|
IQVIA Holdings
IQV
|
93 M | $ 164.94 | 1.75 % | $ 28.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 31.48 | 0.82 % | $ 20 B | ||
|
Biodesix
BDSX
|
719 K | $ 13.28 | 3.99 % | $ 1.72 B | ||
|
Natera
NTRA
|
7.64 M | $ 209.72 | 0.18 % | $ 20.6 B | ||
|
RadNet
RDNT
|
56.6 M | $ 67.3 | -1.87 % | $ 4.92 B | ||
|
Lantheus Holdings
LNTH
|
1.87 M | $ 73.43 | 0.01 % | $ 5.08 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.11 | 0.49 % | $ 4.85 M |